Mabpharm LimitedHKEX: 2181

Voluntary announcement approval from the national medical products administration on the new drug application (nda) of our pipeline product, cmab807x (denosumab injection)

· Issued by Mabpharm Limited via HKEXnews

Mabpharm Limited (2181) Press Release

View Attachment

Company analysis